News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Decision Due Soon on Eli Lilly and Company (JOBS), Daiichi Sankyo Co Ltd. Blood Thinner
September 22, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK, Sept 21 (Reuters) - Two large drug makers, Eli Lilly and Co and Daiichi Sankyo Co Ltd, face a critical U.S. decision this week on their shared blood-clot preventer that could dramatically boost their bottom lines.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Regulatory
MORE ON THIS TOPIC
Drug pricing
Trump Administration Reaches Pricing Agreements with 9 More Drugmakers
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Policy
Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Approvals
Cytokinetics Wins FDA Approval, Clearing Way to Challenge BMS in Heart Disease Market
December 22, 2025
·
2 min read
·
Nick Paul Taylor
ADCs
Patient Deaths Put Merck, Daiichi Sankyo’s Antibody-Drug Conjugate on Hold
December 19, 2025
·
2 min read
·
Tristan Manalac